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404Abstract: Epidemiological studies and meta-analyses report a strong relationship between chronic
pain and abnormalities in glucose metabolism, but the exact relationship between chronic pain and
insulin resistance in type 2 diabetes (T2D) remains unknown. Using a model of neuropathic thermal
and tactile hypersensitivity induced by chronic constriction injury (CCI) of the sciatic nerve in Zucker
Diabetic Fatty (ZDF) and Zucker Lean (ZL) littermates, we compared the recovery period of hypersen-
sitivity and the progression of T2D and studied the possible involvement of insulin receptors (IRs) in
the comorbidity of these 2 conditions. We found that the nociceptive thresholds to thermal and me-
chanical stimulation in naive ZDF rats were lower than in ZL littermates at 6 weeks of age. Although
ZDF and ZL rats developed thermal and tactile hypersensitivity after CCI, it took a longer time noci-
ceptive sensitivity to be restored in ZDF rats. Nerve injury accelerated the progression of T2D in ZDF
rats, shown by an earlier onset of hyperglycemia, more severe hyperinsulinemia, and a higher con-
centration of glycosylated hemoglobin Alc 6 weeks after CCI, compared with those in naive ZDF
and ZL rats. IR-immunoreactive cells were located across the central nervous system and skeletal mus-
cles. In the central nervous system, IR coexpressed with a neuronal marker (neuronal nuclei) but not a
glial marker (glial fibrillary acidic protein). There was a low level of IR expression in skeletal muscles
of naive ZDF rats. In contrast, CCI reduced the IR expression in skeletal muscles as well as the ipsilat-
eral spinal cord, primarily in the dorsal horn. In conclusion, our data suggest that the relationship be-
tween insulin resistance and chronic pain in ZDF rats is bidirectional and an impaired IR signaling
system might be implicated in this reciprocal relationship.
Perspective: Nerve injuries in genetically susceptible individuals might accelerate the development
of insulin resistance as in T2D. A downregulated expression of IRs in the skeletal muscle innervated
by the injured nerve is one of the underlying mechanisms.October 20, 2015; Revised November 29, 2015; Accepted
r 7, 2015.
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ype 2 diabetes (T2D) is a complex metabolic
disorder characterized by hyperglycemia and hy-
perinsulinemia. The incidence of obesity, insulin
resistance, and T2D is increasing at an alarming rate
and represents a significant clinical condition world-
wide. T2D is frequently accompanied with painful
diabetic neuropathy, among many other complications.
Approximately 1 in 3 people with diabetes is affected
by diabetic neuropathy, a major health problem that
might present with excruciating pain and is responsible
for substantial morbidity, increased mortality, and
impaired quality of life.30 However, the exact relation-
ship between chronic pain and T2D remains unclear.
A potential relationship between chronic pain and T2D
might include 2 aspects: the influence of T2D on nocicep-
tion and the effect of chronic pain on the progression of
T2D. As to the former, studies found that: 1) Impaired pe-
ripheral nerve insulin receptor (IR) signaling coincides
with early thermal and tactile hypersensitivity in type 1
diabetic rats24; 2) insulin resistance, with or without
compensatory hyperinsulinemia, is associated with
altered nociception in T2D rats25; 3) in nondiabetic rats
hyperinsulinemia per se tended to show thermal andme-
chanical hypoalgesia25; and 4) consequences of insuline-
mia or insulinemia itself play a role in the impairment of
mechanical nociception.21 Together, these results indi-
cate that diabetes might change nociception threshold,
but the direction of such changes (increase vs decrease)
is unclear. Even less is known regarding the effect of
chronic pain on the progression of T2D.
The genetically leptin-receptor deficient Zucker
Diabetic Fatty (ZDF) rats develop obesity, insulin resis-
tance, and T2D naturally. In this study, we used ZDF rats
as a diabetic model and Zucker Lean (ZL) rats as controls
to study a correlative relationship between the progres-
sion of T2D and changes in nociceptive threshold. We
also examinedwhether there is a downregulated expres-
sion of IRs in the central nervous system in this process.CCI operaƟon aŌer  
baseline tests
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Figure 1. Experimental arrangement and time points in weeks.
Showing the time points of events and the animal arrangement
in 3 separate experimental processes: (A) nociceptive tests; (B)
nociceptive and blood glucose tests; (C) sampling in CCI oper-
ated animals. Numbers and time points are in weeks.Methods
Diabetic Animal Model
ZDF (fa/fa; n = 35) rats and ZL (1/fa; n = 21) littermates
5 weeks old were purchased from Vital River Labora-
tories International Inc (Beijing, China). The number of
rats was calculated using power analysis (.8), considering
the data variation of postprocedure nociceptive
behavior and of blood glucose level in ZDF rats. Litter-
mates from the same or foster mother were housed in
a specific pathogen-free condition, in a large plastic
cage with wood chip bedding, distilled water, and stan-
dard rat diet pellets available ad libitum. Animals were
housed under controlled temperature (21C6 2C), rela-
tive humidity (50% 6 10%) and artificial light (12-hourlight and dark cycle, lights on at 7 AM). Rats entered the
experimental procedures (divided into 3 separate exper-
iments, A, B, and C) at 6 weeks of age, as shown in Fig 1.
We used only male ZDF and ZL littermates to avoid a
possible confounding effect from sex and age differ-
ences on the levels of endogenous glucagon, insulin,
and other possible hormones. The experimental protocol
was approved by the Institutional Animal Care and Use
Committee of the China Academy of ChineseMedical Sci-
ences. The care and use of animals conformed to appli-
cable national and international guidelines. Principles
of laboratory animal care were followed.Preparation of Chronic Constriction
Injury or Sham Animals
In this study chronic constriction injury (CCI) of a uni-
lateral sciatic nerve was produced by placing loose liga-
tions at the common sciatic nerve according to the
method of Bennett and Xie.5 Briefly, under 2% isoflur-
ane anesthesia, the right side sciatic nerve was exposed
in the mid thigh and 4 loose ligatures with 1.0- to
1.5-mm intervals were made around the nerve trunk
using 4-0 chromic gut suture. The nerve trunk was then
put back in its original position and the wound closed
using sterilized wound clips. For sham rats we made
the same surgical procedure except for the nerve liga-
tion. No further analgesics were used after the CCI or
sham procedure to avoid any unwanted effects.Behavioral Testing
Experiment A was meant to compare the nociceptive
threshold at baseline and after the CCI procedure
406 The Journal of Pain Chronic Pain Accelerates Type 2 Diabetesbetween ZDF (n = 7) and ZL (n = 5) rats without use of the
sham procedure for the purpose of conserving rats. A
ZDF rat was excluded from further experiments because
of postoperative paralysis and poor grooming.
The withdrawal threshold to thermal and mechanical
stimulation was examined in each animal separately for
the ipsilateral and contralateral hind paw before (base-
line) and at various postprocedure time points up to
10 weeks. Animals were habituated to the test environ-
ment (behavior testing room) daily (a 60-minute session)
for 2 days before baseline testing. All testing was con-
ducted between 9:00 AM and 1 PM by an experimenter
(C.S.) who was blinded to the group assignment.
To measure tactile sensitivity threshold, rats were
placed into a plastic cage with a wire mesh bottom and
examined by applying a von Frey filament to the plantar
surface of each hind paw.26,28 The von Frey filament set
has a calibrated range of bending force (26, 15, 10, 8,
6, 4, 2, 1.4, 1, .6, .4, .16, and .007g). A single filament
was applied to the plantar surface 5 times with an
interstimulation interval of 5 seconds. A positive
response was defined as at least 1 clear withdrawal
response in the 5 applications. The filament was
applied in an up-and-down fashion according to a nega-
tive or positive response.
Thermal hypersensitivity to radiant heat was deter-
mined according to a previously described method12,28
using a 390 Analgesia Meter (IITC Inc, Woodland Hills,
CA). Briefly, rats were placed individually into a
plexiglass cubicle on a transparent glass surface. The
light source from a projection bulb, located below the
glass, was directed at the plantar surface of 1 hind
paw. The foot withdrawal latency was defined as the
time from the onset of radiant heat to withdrawal of
the tested paw. The radiant heat source was adjusted
to result in baseline latencies of approximately
12 seconds and a cutoff time at 20 seconds. Two trials
with an intertrial interval of 5 minutes were made for
each hind paw and scores from both trials were
averaged to yield mean withdrawal latency for the
hind paw.Glucose Concentration Testing
In experiment B, rats (ZDF, n = 18; ZL, n = 10) were
tested for randomglucose concentration using anAscen-
sia Breeze Blood Glucose Monitoring System (Newbury,
Berks, United Kingdom). The glucose concentration is
used as a routine test to determine the progression of
blood glucose metabolism dysfunction. Tail tip blood
samples were taken between 9- and 10 AM while rats
were restrained in a plastic cone. The blood glucose con-
centration test range was .6 to 33.3 mmol/L. Any concen-
tration greater than the testing limit was recorded as
33.3 mmol/L for statistical purposes.Plasma Glycohemoglobin Concentration
Hemoglobin A1c (HbA1c) is a minor hemoglobin
component of erythrocytes and its sugar moiety is
glucose covalently bound to the terminal amino acid of
the b chain. Because glycohemoglobin concentration isnot influenced by short-term blood glucose fluctuations
over the preceding several weeks, the concentration of
HbA1c is a more reliable index of the blood sugar
average over a long period of time and is used to eval-
uate the development of a diabetic condition.
For analysis of plasmaHbA1c concentration, blood sam-
ples were taken from left heart ventricles upon sacrifice,
centrifuged for 10 minutes at 110g, 4C to obtain plasma.
All plasma sample–containing tubes were wrapped in foil
and stored at 80C until use. The concentration of
plasma HbA1c was evaluated using enzyme-linked immu-
nosorbent assay kits purchased from R&D Systems (Bei-
jing, China) and analyzed by Huanya Biomedicine
Technology Co LTD (Beijing, China). Results were read us-
ing a microplate reader (Multiskan MK3; Thermo Scienti-
fic, Beijing, China) at wavelengths of 450 nm.Western Blot Analyses
In experiment C, ZDF (naive and CCI, n = 4 each) and ZL
rats (naive and CCI, n = 2 each) were sacrificed 2 weeks
after the procedure. Fresh tissues of spinal cord dorsal
horn from the lumbar enlargement (left and right sepa-
rately) and skeletal muscles were collected and saved at
80C until use. The samples were homogenized in so-
dium dodecyl (lauryl) sulfate (SDS) buffer containing a
mixture of proteinase inhibitors (Sigma, St. Louis, MO).
Protein samples were separated on an SDS-
polyacrylamide gel electrophoresis gel (4–15% gradient
gel; Bio-Rad, Hercules, CA) and transferred to polyvinyli-
dene difluoride membranes (Millipore, Bedford, MA).
The membranes were blocked with 3% milk and
incubated overnight at 4C with a primary antibody to
IR (95 kD, rabbit polyclonal anti-IR b antibody [C18C4;
ab69508], 1:5,000; Abcam, Cambridge, MA). After
rinsing with phosphate-buffered saline 3 times for 10mi-
nutes, the membranes were incubated at room tempera-
ture with horseradish peroxidase–conjugated secondary
antibody (1:10,000; Abcam) for 1 hour. The blots were
visualized in ECL solution (NEN, Boston,MA) for 1minute
and exposed on hyperfilms (Amersham Biosciences, Bei-
jing, China) for 1 to 10 minutes. The membranes were
then incubated in a stripping buffer (67.5 mm Tris, pH
6.8, 2% SDS, and 0.7% b-mercaptoethanol) for 30 mi-
nutes at 50C and reprobed with a polyclonal rabbit
anti-glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) antibody (1:20,000; Beijing TDY Biotec, Beijing,
China) as a loading control. The Western blot analysis
was done in triplicate to produce a quantitative result.
The density and size of the bands was measured with a
computer-assisted imaging analysis system and normal-
ized against loading controls.Immunohistochemical Staining
Rats (ZDF, n = 2; ZL, n = 2) were anesthetized with
pentobarbital (60mg/kg, intraperitoneally) and transcar-
dially perfused with 200 mL cold saline followed by
400 mL cold 4% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.35). Tissues of brain and spinal cord were
dissected, postfixed for 2 hours, and kept in 30% sucrose
in 0.1 M phosphate buffer at 4C until they sank to the
Zhai et al The Journal of Pain 407bottom. Tissues were then cut using a cryostat (30 mm)
and mounted onto microscope slides. Immunohisto-
chemical staining was used to detect the qualitative
expression of IR (rabbit polyclonal anti-IR b antibody
[C18C4], 1:2,000; Abcam). For double immunolabeling
of IR and neuronal nuclei (NeuN; mouse monoclonal
anti-NeuNantibody, 1:1,000; Abcam) or IR andglial fibril-
lary acidic protein (GFAP; chicken polyclonal anti-GFAP
antibody, 1:1,000; Abcam) primary antibodies were incu-
bated together. Sections were blocked with 1% goat
serum in 0.3% Triton X-100 for 1 hour at room tempera-
ture and incubated overnight at 4C with the primary
antibody. For controls, the primary antibody was
omitted. The sections were then incubated for 1 hour
at room temperaturewith corresponding fluorescein iso-
thiocyanate- or cyanine dye 3-conjugated secondary
antibody (1:200; Jackson ImmunoResearch, West Grove,
PA). Slides were read using a LEXT OLS4000 3D Laser
Measuring Microscope (Olympus, Center Valley, PA)
and recorded using a digital camera.Statistical Analysis
The raw data from blood glucose tests, HbA1c, and
nociceptive sensitivity tests were analyzed using 1-way
repeated measures analysis of variance across testing
time points to detect overall differences among treat-
ment groups (SigmaPlot version 11.0 for Windows;
San Jose, CA). When significant main effects were
observed, the Holm–Sidak tests were performed to
determine sources of differences. Data from enzyme-
linked immunosorbent assay and Western blot analyses
were analyzed using the Student t-test to detect differ-
ences between treatment groups. The data are pre-
sented as mean 6 standard error. Differences were
considered to be statistically significant at the level
of a = .05.
To determine the association of nociceptive threshold
to glucose concentration in ZDF rats, data were analyzed
using SigmaPlot by comparing raw data at different time
points (0, 2, and 6 weeks) in separate CCI and naive
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Lower Nociceptive Threshold and
Prolonged Recovery Period of
Nociceptive Sensitivity in ZDF Rats
In naive rats, baseline nociceptive thresholds to ther-
mal and mechanical stimulation were lower in ZDF rats
than in ZL littermates at the age of 6 weeks. After the
CCI procedure, ZDF and ZL rats developed thermal and
tactile hypersensitivity. Although it took approximately
6 weeks after the procedure for the lower nociceptive
thresholds to restore in ZL rats, it took approximately
8 weeks after the procedure for thermal hypersensitivity,
and 10 weeks after the procedure for mechanical hyper-
sensitivity to restore in ZDF rats (Fig 2).Deteriorated Glucose Metabolism in ZDF
Rats With CCI
As detected between 6 weeks (used as baseline) and
12 weeks of age, the blood glucose concentration in
naive ZDF rats gradually increased, such that, by 10weeks
of age, the glucose concentration was significantly
higher than baseline. In ZDF rats with CCI, beginning
from the second postprocedure week (ie, 8 weeks of
age) the blood glucose was already significantly higher.
Beginning from the third postprocedure week, CCI rats
showed a consistently higher blood glucose concentra-
tion than in naive ZDF rats (Fig 3A). Hyperglycemia
related to nociceptive hypersensitivity was not present
in ZL rats (Fig 3B). Although the sham-CCI rats showed
a brief nociceptive sensitivity of 1 to 3 days, there was
no observable blood glucose level change at any experi-
mental time point (results not separately shown). This
result indicates that a brief (acute) hypersensitivitymight
not induce a significant influence on the blood glucose
level. At 12 weeks of age, the concentration of HbA1c
in naive ZDF rats was higher than in naive ZL littermates.
Although the concentration of HbA1c in ZL rats with CCI
did not differ from that in naive ZL rats, it was signifi-
cantly increased in ZDF rats with CCI compared with
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Figure 3. Influence of CCI on bloodglucose concentration. Therewas an acceleratedprogression of hyperglycemia in (A) ZDF but not
(B) ZL rats after the CCI procedure. *, **, ***, P < .05, .01, .001 compared with baseline of the same group, respectively; #P < .05
compared with the naive group at the same time point. Abbreviations: CCI, chronic sciatic nerve constriction injury group of rats;
Bas, baseline data before the procedure; D, postprocedure time in days; W, postprocedure time in weeks.
408 The Journal of Pain Chronic Pain Accelerates Type 2 DiabetesParadoxically, the insulin concentration at the time of
sampling was higher in naive ZDF than in ZL rats. The CCI
procedure in ZDF rats increased insulin to a significantly
higher level in contrast to the change in ZL rats with CCI
(Fig 4B). Combined with the hyperglycemia, these results
indicate a deteriorated insulin resistance after the CCI
procedure.Correlation Between Nociceptive
Threshold and Glucose Concentration in
ZDF Rats
There was a correlation between nociceptive
threshold and glucose concentration in CCI and naive
ZDF rats (Fig 5). In ZDF rats with CCI, the correlation
dots collectively shifted to the lower nociceptive area
first and then to the higher glucose concentration area
(Figs 5A and 5C).When data from all 3 time points (weeks
0, 2, and 6) were analyzed together, there was a strong
negative correlation between glucose concentration
and nociceptive threshold in CCI rats (for thermal stimu-
lation, r = .759; for mechanical stimulation, r = .718),
in contrast to a moderate negative correlation in naiveZL ZL/CCI ZDF ZDF/CCI
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Figs 5B and 5D, and Table 1).Lower Expression of IR in the Skeletal
Muscle and Spinal Cord of Naive ZDF Rats
and Downregulated Expression of IR in
CCI Rats
Western blot analysis showed that, although IR expres-
sion was comparable in liver and hypothalamus of naive
ZL and ZDF littermates (data not shown), it was signifi-
cantly lower in the skeletal muscles and the spinal cord
dorsal horn of naive ZDF rats. This was further decreased
in CCI rats 2 weeks after the procedure, particularly in
ZDF rats (Fig 6). Additionally, immunofluorescence re-
sults showed that IR expression in the ipsilateral spinal
cord dorsal horn was lower in ZL rats with CCI (Fig 7).
Double-labeling immunofluorescence showed that IR
expression in the brain was colocalized with the
neuronal marker NeuN (Figs 8A–8H) but not the glial
marker GFAP (Figs 8I–8L). Every IR-positive cerebral cell
was also NeuN-immunoreactive but only a small of
number NeuN-positive cells were IR-immunoreactive.ZL ZL/CCI ZDF ZDF/CCI
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Figure 5. Association between nociceptive threshold and glucose concentration. (A) Thermal hyperalgesia threshold and (C) me-
chanical allodynia latency are negatively associated with blood glucose concentration. (A) and (C)There was a strong correlation in
rats that received the CCI procedure and (B) and (D) a moderate correlation in naive ZDF rats. This suggests that CCI might deteriorate
the glucose metabolism dysfunction (hyperglycemia) in ZDF rats. Abbreviations: W0, W2, W6, Week 0, 2, and 6, respectively.
Zhai et al The Journal of Pain 409However, a much higher number of NeuN-positive cells
were also IR-positive in the spinal cord dorsal horn
compared with in the brain.Conclusions
In this study we found that: 1) ZDF rats have a lower
nociceptive threshold, 2) ZDF rats with CCI showed a de-
layed restoration from nociceptive hypersensitivity, and
3) the presence of nociception in ZDF rats accelerated
the progression of T2D.Table 1. Correlations Between Glucose
Concentration and Nociceptive Threshold in
ZDF Rats
VARIABLE CCI NAIVE
Estimated glucose level
from thermal threshold
y = 46.087-2.918x
R = .759
y = 31.964-1.472x
R = .465
Estimated glucose level
from mechanical
threshold
y = 25.315-1.54x
R = .718
y = 20.947-0.647x
R = .209
Estimated thermal
threshold from glucose
level
y = 13.009-0.197x
R = .759
y = 13.252-0.147x
R = .465
Estimated mechanical
threshold from glucose
level
y = 10.517-0.334x
R = .718
y = 8.907-0.068x
R = .209ZDF rats have a missense mutation in the leptin recep-
tor gene and are widely used for diabetes and obesity
studies. Leptin is an adipokine and hormone that plays
a key role in regulating energy intake and expenditure,
including appetite and hunger, metabolism, and
behavior.6 Leptin functions by binding to the leptin re-
ceptor. Without a functional leptin signaling system,
the leptin receptor-deficient db/db mice develop
T2D-like conditions, obesity, and hypertension. Addi-
tionally, db/db rodents exhibited features that could be
found in humans with diabetic autonomic neuropathy
and thus could serve as a preclinical model for this condi-
tion.10 The CCI model in ZDF rats was used in this study to
mimic diabetic neuropathy, because it provides
conditions of obesity, a high level of blood glucose,
chronic thermal and tactile hypersensitivity, and a mech-
anism of partial vessel interruption (arteriosclerosis in
the arteriole) in the nerve trunk. Although ZDF rats natu-
rally develop obesity, insulin resistance, and T2D, our re-
sults show that chronic pain accelerates the progression
of these conditions.
It has been reported that at 8 weeks of age, ZDF rats
develop T2D with insulin resistance and decreased
b-cell function.1 In the current study, ZDF rats at 6 weeks
of age showed signs of hyperglycemia with lower noci-
ceptive thresholds to thermal and mechanical stimuli,
compared with naive ZL rats. The leptin signaling system
has been proven to be involved in nociceptive
ZL ZL/CCI ZDF ZDF/CCI
R
e
la
ti
v
e
 d
e
n
s
it
y
0.0
0.5
1.0
1.5
2.0
2.5
3.0
* *
**
#
A     C
GAPDH
IR
Na ve Cont Ipsi Na ve Cont IpsiNai i i i i ive CCI Na ve CCI
ZL ZDF ZDF
Na ve CCI Na ve CCI
ZL ZDF
ZL ZL/CCI ZDF ZDF/CCI
R
el
at
iv
e 
d
en
si
ty
0
2
4
6
8
* *
***
##
A’ B’   C’  
ZDF Cont Ipsi
R
el
at
iv
e 
d
en
si
ty
0
1
2
3
4
5 *
**
#
B
Figure 6. Expression of IR in (A) spinal cord dorsal horn and (B) and (C) skeletal muscles of naive and CCI rats. Western blots show a
lower expression IR in (A) spinal cord and (B) skeletal muscles of naive ZDF rats as comparedwith that in naive ZL rats. Twoweeks after
the CCI procedure the expression of IR was further downregulated in ZL and ZDF rats, with a stronger effect in ZDF rats (B). *, **, ***,
P < .05, .01, .001, respectively, compared with naive ZL rats. #, ##, P < .05, .01, respectively, compared with naive ZDF rats. Compared
within ZDF rats alone, the expression of IR in the skeletal muscle directly innervated by CCI procedure nerve was significantly down-
regulated and it was somewhat upregulated in the contralateral skeletal muscle (C). (A’), (B’), and (C’) show relative density (in pixels)
of IR blots in panels (A), (B), and (C), respectively. *, **, P < .05, .01, respectively, comparedwith naive ZDF rats. #P < .05, comparedwith
contralateral. Abbreviations: Cont, skeletal muscle innervated by contralateral sciatic nerve; Ipsi, skeletal muscle directly innervated
by CCI procedure sciatic nerve.
410 The Journal of Pain Chronic Pain Accelerates Type 2 Diabetessensitivity.27 The different nociceptive sensitivity be-
tween ZDF and ZL rats of 6 weeks of age might be
because of the leptin receptor expression deficit in ZDF
rats. Notably, after another 6 weeks (12 weeks of age)
in a neuropathic pain condition, ZDF rats showed hyper-
insulinemia and a higher HbA1c level, and naturally at
12 weeks of age, the insulin concentration in naive ZDF
rats was not significantly higher than that in ZL rats.
These results indicate that: 1) lower nociceptive thresh-
olds and hyperglycemia developed early, 2) they might
develop simultaneously, 3) CCI provides additive hyperal-
gesia to diabetes and the eventual nociceptive recoveryFigure 7. Expression of IR-positive cells in the spinal cord of a
ZL rat 2weeks after the CCI procedure. There is a downregulated
expression of IR-immunopositive cells (green) in the spinal cord
ipsilateral to the CCI procedure. Bar, 250 mm. Abbreviations:
Cont, control lateral to the CCI procedure; Ipsi, ipsilateral to
the CCI procedure; Dorsal, dorsal part of spinal cord; Ventral,
ventral part of spinal cord.does not include restoration to nondiabetic values; and
4) a condition of chronic nociception hypersensitive ex-
acerbates insulin resistance in ZDF rats. The correlation
between nociceptive threshold and blood glucose con-
centration supports these viewpoints. Recovery of hyper-
algesia in nerve injury models has been attributed to
regeneration and reinnervation.9 The delayed nocicep-
tive hypersensitivity recovery seen in the diabetic rats
with CCI could arise from the delayed nerve regeneration
that is commonly reported in diabetic rodents.13
However, our results also suggest that the downregu-
lated expression of IRs might be part of a shared mecha-
nism between insulin resistance and nociceptive
hypersensitivity.
Biological actions of insulin are initiated by binding to
its cell surface receptor, which results in autophosphory-
lation of the receptor, activation of its intrinsic tyrosine
kinase activity,20,22 and finally, activation of
intracellular pathways.29 Insulin receptors are also
widely expressed in peripheral neurons in the cell body
and in axons.3,4,18 Neurons indeed develop insulin
resistance after hyperinsulinemia in a manner similar to
that in metabolic tissues.17 In a previous study, after dia-
betic neuropathy was induced in a type 1 diabetes rat
model, treatment with low-dose insulin normalized
behavioral scores in 5 weeks, although severe hypergly-
cemia remained, indicating that impaired insulin
signaling does play a role in the pathophysiology of
painful diabetic neuropathy.14
Acute pain has been reported to reduce insulin sensi-
tivity in patients due to a decreased glucose uptake in
the body.11 In this study, CCI resulted in anacute condition
of hypersensitivity and transition to a chronic condition at
8 weeks. Although the behavior eventually recovered
with time, the T2D persisted. Therefore, although the
Figure 8. Colocalization of IR-immunoreactivity with NeuN but not GFAP in the brain and spinal cord dorsal horn of ZL rats.
Although IR-positive cells (green) were all NeuN-reactive in (A-D) brain and (E-H) spinal cord dorsal horn, a much higher ratio of
the NeuN-positive cells were IR-positive in the spinal cord dorsal horn compared with in the brain. There was no colocalization be-
tween IR (green) and GFAP (I-L). Bar, 100 mm. Abbreviation: DAPI, 40,6-diamidino-2-phenylindole.
Zhai et al The Journal of Pain 411change in sensitivity reduced insulin sensitivity, there
might be other mechanisms for the accelerated T2D pro-
gression induced by CCI. In this study, we examined the
expression of IRs in the spinal cord and skeletal muscles
in naive ZDF and ZL rats, aswell as in CCI rats 2weeks after
the procedure. We found that the expression level of IRs
was lower in tissues taken from naive ZDF rats and was
even lower in ZDF and ZL rats with CCI. Our data suggest
that the downregulation of IRs secondary to CCI mightoccur in multiple loci in the body, including the central
nervous system, liver, skeletal muscle, and adipose and
other metabolic tissues, which might serve as a possible
mechanism underlying a reciprocal relationship between
chronic pain and the progression of T2D.
Because IR is necessary for the body cells to use
glucose, the IR signaling system in the skeletal muscle
might be involved in the motor function of the muscle.
However, the low expression of IR in skeletal muscles
Figure 8. (continued)
412 The Journal of Pain Chronic Pain Accelerates Type 2 Diabetesmost likely would delay the behavioral response instead
of shorten the response time. Thus the behavioral sensi-
tivity to thermal andmechanical stimuli in ZDF rats, espe-
cially after the CCI procedure, might not be the results of
motor function failure.
Previous studies have shown that: 1) obesity is themain
cause of T2D23 and over a third of American adults are
considered obese,8 2) the prevalence of chronic pain var-
ied from 10.1% to 55.2% of the population around the
world,7,16 3) as of 2013, it was estimated that there
were 382 million people with T2D worldwide, making
up approximately 90% of diabetes cases and equivalent
to approximately 8.3% of the world’s adult
population,15 and 4) in the United States alone, 11.3%
of adults aged 20 years and older have T2D and this
increases to 25.9% in adults aged 65 years and older.2,19Our results showed that T2D exacerbates chronic pain
and chronic neuropathic pain accelerates the
progression of T2D in ZDF rats. Although the exact
cellular mechanism of this relationship remains to be
elucidated, our data suggest that adequate treatment
of chronic pain in patients who are genetically and
environmentally susceptible to obesity and diabetes
might be a key step to break a vicious cycle of T2D and
pain progression.Acknowledgments
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